Drug Discovery World
MAY 10, 2023
Regulatory agencies such as the US Food & Drug Administration (FDA), European Medicines Agency (EMA), and the China National Medical Products Administration (NMPA) adhere to these guidelines and require that novel small molecule compounds intended for continuous or intermittent use undergo specific types of carcinogenicity testing studies.
Drug Discovery World
NOVEMBER 9, 2023
James Cooke, PhD, Associate Director, Bicycle Therapeutics, on: ‘Engineering bicyclic peptides for precision targeted medicine’. Marine Houdou, Genetic Engineering Specialist, Polyplus, on: ‘From modular DNA assembly to recombinant protein production at Polyplus’.
The Pharma Data
MAY 13, 2021
The Yale Journal of Biology and Medicine. Preventive Medicine Reports. Experimental & Molecular Medicine. Journal of addiction medicine. Aspartame bioassay findings portend human cancer hazards. Neural and Genetic Correlates of the Social Sharing of Happiness. Neuroendocrinology of obesity. Br Med Bull.
Expert insights. Personalized for you.
52 
Let's personalize your content